communityacquir
pneumonia
may
present
similar
clinic
symptom
regardless
viral
bacteri
caus
diagnost
assay
need
rapidli
discrimin
caus
guid
decis
appropri
treatment
therefor
quantit
realtim
pcr
qpcr
assay
duplex
reaction
target
eight
bacteria
six
virus
develop
technic
perform
examin
linear
plasmid
upper
lower
respiratori
tract
specimen
use
compar
qpcr
assay
standard
microbiolog
method
limit
detect
dna
templat
copi
approxim
differ
concentr
two
compet
templat
sd
posit
control
use
qpcr
assay
result
posit
identif
respiratori
specimen
compar
use
standard
diagnost
diagnost
accuraci
qpcr
assay
vari
posit
agreement
standard
test
streptococcu
pneumonia
mycoplasma
pneumonia
moraxella
catarrhali
staphylococcu
aureu
neg
percentag
agreement
pneumonia
streptococcu
pyogen
respiratori
syncyti
viru
influenza
viru
wherea
haemophilu
influenza
multipl
microbi
agent
identifi
sputum
nasopharynx
specimen
conclud
parallel
qpcr
detect
target
respiratori
bacteria
virus
feasibl
result
indic
good
technic
perform
assay
clinic
specimen
communityacquir
pneumonia
cap
repres
major
challeng
institut
ration
medic
treatment
divers
caus
virus
bacteria
may
present
similar
symptom
make
difficult
distinguish
clinic
physician
lack
inform
caus
agent
decis
appropri
treatment
lead
increas
use
ecolog
unfavor
broadspectrum
antibiot
provid
appropri
target
treatment
physician
need
diagnost
method
rapid
sensit
specif
combin
current
standard
diagnost
method
lack
although
present
viral
diagnost
mostli
reli
nucleic
acid
detect
properti
tradit
cultiv
techniqu
bacteria
limit
possibl
develop
rapid
method
detect
tent
caus
thu
number
recent
studi
aim
develop
molecular
method
detect
bacteri
viral
pathogen
overcom
limit
cultiv
quantit
realtim
pcr
qpcr
assay
implement
allow
rapid
detect
gener
applic
method
implement
common
bacteri
pathogen
streptococcu
pneumonia
staphylococcu
aureu
streptococcu
pyogen
haemophilu
influenza
moraxella
catarrhali
legionella
pneumophila
mycoplasma
pneumonia
chlamydophila
pneumonia
vast
number
studi
also
explor
diagnost
qpcr
viral
caus
cap
particular
influenza
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
nevertheless
studi
aim
develop
combin
molecular
detect
assay
virus
bacteria
relev
cap
recent
evalu
two
avail
system
found
although
one
clinic
relev
pathogen
could
readili
detect
perform
limit
two
pathogen
present
specimen
rapid
turnaround
time
low
limit
detect
implement
nucleic
acidbas
detect
method
cap
pathogen
may
shorten
time
diagnosi
increas
sensit
standard
cultiv
method
provid
limit
sensit
import
caus
includ
h
influenza
probabl
fastidi
natur
bacterium
even
pneumonia
autolyt
behavior
latter
seem
surviv
poorli
transport
cultiv
fulli
take
advantag
molecular
method
sensit
specif
target
gene
must
chosen
care
capit
previou
work
valid
suitabl
target
sever
respiratori
pathogen
develop
qpcr
assay
caus
diagnosi
cap
emphas
high
technic
perform
includ
abil
detect
coinfect
multipl
pathogen
present
differ
concentr
present
multiplex
qpcr
method
simultan
detect
eight
bacteri
six
viral
pathogen
relev
diagnosi
cap
experiment
practic
design
perform
interpret
qpcr
experi
work
conduct
maximum
possibl
extent
accord
guidelin
minimum
inform
public
qpcr
experi
sputum
specimen
homogen
equal
volum
nacetyl
cystein
solut
describ
previous
extract
nucleic
acid
autom
dnarna
extract
nordiag
arrow
instrument
viral
na
kit
diasorin
saluggia
vc
itali
use
clinic
specimen
viral
strain
sampl
volum
ml
elut
volum
ml
eluat
clinic
sampl
dilut
ml
nucleasefre
water
ambion
life
technolog
carlsbad
ca
store
c
analysi
dna
bacteri
strain
extract
previous
describ
method
base
bind
dna
uniform
glass
bead
store
c
analysi
plasmid
dna
extract
qiaprep
spin
miniprep
kit
qiagen
inc
valencia
ca
accord
manufactur
instruct
linear
plasmid
insert
target
sequenc
use
posit
control
assay
plasmid
order
eurofin
mwg
operon
ebersberg
germani
except
plasmid
use
c
pneumonia
inhous
construct
plasmid
transform
one
shot
electrocom
escherichia
coli
invitrogen
life
technolog
carlsbad
ca
cell
plate
kanamycincontain
luria
brothagar
plate
singl
coloni
use
dna
extract
describ
dna
rna
extract
concentr
measur
duplic
nanodrop
spectrophotomet
nanodrop
technolog
wilmington
de
posit
control
solut
plasmid
bold
indic
use
primer
mix
target
two
differ
base
detect
influenza
two
differ
primer
pair
use
studi
new
influenza
strain
emerg
adjust
assay
accordingli
journal
molecular
diagnosticsjmdamjpatholorg
copi
per
ml
correspond
plasmid
copi
per
ml
pcr
reaction
prepar
primer
probe
sequenc
l
pneumophila
pneumonia
catarrhali
c
pneumonia
aureu
piv
type
rsv
influenza
b
obtain
previou
public
pcr
condit
optim
duplex
reaction
tabl
new
influenza
strain
point
mutat
target
sequenc
primer
probe
influenza
assay
appear
cours
work
qpcr
assay
therefor
updat
accord
recommend
public
health
agenc
sweden
bryt
unpublish
data
includ
assaydenot
influenza
primer
probe
h
influenza
pneumonia
alreadi
establish
uniplex
qpcr
assay
analysi
spinal
fluid
laboratori
publish
primer
probe
pyogen
construct
primer
express
version
appli
biosystem
life
technolog
carlsbad
ca
probe
use
hydrolysi
technolog
black
hole
quencher
fluorophor
vic
appli
biosystem
taqman
fast
advanc
master
mix
dna
detect
taqman
fast
viru
master
mix
rna
detect
use
bacteria
virus
respect
appli
biosystem
total
reaction
volum
ml
consist
ml
rna
master
mix
primer
probe
nucleasefre
water
ml
templat
clinic
specimen
run
includ
triplic
notempl
control
duplic
posit
control
amplif
detect
analysi
perform
fast
realtim
pcr
system
appli
biosystem
thermal
profil
minut
c
second
c
subsequ
cycl
second
c
second
c
duplex
qpcr
assay
combin
describ
tabl
analyt
specif
primer
probe
test
bioinformat
experiment
primer
blast
test
panel
refer
strain
supplement
tabl
respect
limit
detect
assess
recommend
serial
dilut
linear
plasmid
use
six
replic
concentr
copi
per
reaction
respect
abil
duplex
assay
simultan
detect
agent
target
test
keep
one
agent
high
concentr
copi
per
reaction
test
agent
equal
concentr
use
limit
detect
defin
concentr
six
replic
detect
theoret
reason
five
copi
per
reaction
set
detect
limit
experi
approv
zero
one
six
replic
dilut
posit
effici
test
dilut
seri
plasmid
standard
rang
approxim
copi
per
reaction
equal
concentr
target
duplex
reaction
analys
perform
duplic
triplic
detect
least
five
dilut
step
requir
approv
result
standard
curv
gener
plot
quantif
cycl
cq
valu
concentr
linear
r
valu
slope
standard
curv
calcul
data
analysi
program
sd
version
appli
biosystem
reproduc
assay
assess
compar
posit
control
result
run
two
separ
analysi
batch
perform
month
apart
two
person
use
separ
plasmid
prepar
dilut
seri
rel
sd
cq
valu
calcul
measur
stabil
addit
reproduc
assess
clinic
specimen
spike
presenc
frequenc
pcr
inhibit
investig
analysi
clinic
nasopharyng
aspir
npa
sputum
specimen
previous
describ
specimen
spike
copi
per
reaction
plasmid
standard
result
normal
mean
copi
per
reaction
posit
control
run
absenc
signal
normal
cq
valu
sd
mean
posit
control
consid
inhibit
verifi
method
could
detect
virus
sputum
sputum
specimen
volum
ml
spike
ml
npa
specimen
posit
either
rsv
influenza
nucleic
acid
extract
qpcr
assay
analysi
perform
describ
section
dna
rna
extract
primer
probe
qpcr
condit
respect
lower
respiratori
tract
specimen
expector
induc
sputum
upper
respiratori
tract
specimen
npa
sent
respiratori
infect
diagnost
clinic
microbiolog
laboratori
norrland
universitetssjukhu
sweden
consecut
includ
evalu
qpcr
assay
sputum
specimen
origin
volum
ml
leucocyt
epitheli
cell
per
power
field
determin
gram
stain
includ
sputum
specimen
split
one
portion
standard
test
anoth
storag
c
use
evalu
qpcr
assay
cultur
specimen
treat
volum
nacetyl
cystein
dilut
phosphatebuff
salin
qpcr
assay
run
small
batch
parallel
standard
microbiolog
test
result
includ
laboratori
report
sent
clinician
analysi
sensit
given
target
duplex
reaction
reveal
panel
indic
good
amplif
linear
effici
sensit
test
target
tabl
limit
detect
target
vari
journal
molecular
diagnosticsjmdamjpatholorg
copi
approxim
differ
templat
concentr
reproduc
test
found
calcul
rel
sd
posit
control
run
intrarun
variabl
assay
highposit
sampl
lowposit
sampl
pcr
amplif
inhibit
use
clinic
specimen
spike
control
plasmid
low
agent
variat
cq
valu
cycl
compar
posit
control
figur
substanti
inhibit
present
sputum
specimen
test
detect
system
inhibit
respect
two
addit
sputum
specimen
one
npa
specimen
result
detect
system
sd
mean
posit
control
indic
presenc
limit
inhibit
evalu
assay
perform
detect
viru
sputum
found
sputum
specimen
spike
influenza
aor
rsvcontain
npa
specimen
posit
ae
n
z
ae
n
z
cycl
respect
among
sputum
specimen
consecut
collect
octob
novemb
elig
inclus
patient
median
age
year
rang
year
n
z
malefemal
distribut
standard
bacteri
cultur
identifi
common
respiratori
pathogen
specimen
pneumonia
n
z
catarrhali
n
z
aureu
n
z
h
influenza
n
z
addit
klebsiella
spp
identifi
three
specimen
exophiala
dermatitidi
one
specimen
fifti
npa
specimen
consecut
collect
januari
januari
patient
median
age
year
rang
year
n
z
malefemal
distribut
nasopharyng
swab
bacteri
cultur
result
avail
specimen
find
pneumonia
n
z
catarrhali
n
z
h
influenza
n
z
standard
qpcr
result
avail
influenza
b
specimen
c
pneumonia
pneumonia
rsv
posit
identif
pneumonia
n
z
rsv
n
z
influenza
n
z
standard
diagnost
test
l
pneumophila
perform
result
qpcr
assay
shown
tabl
measur
agreement
result
standard
microbiolog
test
qpcr
assay
shown
tabl
posit
percentag
agreement
vari
pneumonia
pneumonia
catarrhali
aureu
rsv
neg
percentag
agreement
exceed
pneumonia
pyogen
rsv
influenza
lowest
h
influenza
overal
qpcr
assay
detect
higher
number
microbi
agent
compar
standard
diagnost
method
total
agent
respect
differ
diagnost
yield
larg
part
result
panel
design
qpcr
assay
constantli
target
eight
bacteri
six
organ
number
result
sputum
specimen
volum
consum
duplex
reaction
could
complet
cq
quantit
valu
npa
nasopharyng
aspir
qpcr
quantit
realtim
pcr
rsv
respiratori
syncyti
viru
jmdamjpatholorg
journal
molecular
diagnost
viral
agent
compar
standard
diagnost
test
variabl
appli
respiratori
specimen
correspond
patient
npa
specimen
test
qpcr
assay
analyz
standard
test
specif
virus
pneumonia
c
pneumonia
correspond
respiratori
specimen
test
presenc
bacteria
nineteen
addit
observ
bacteria
result
use
qpcr
assay
sputum
specimen
test
standard
cultur
test
correspond
test
perform
identifi
virus
difficulttocultur
bacteria
two
addit
pneumonia
addit
observ
virus
result
use
qpcr
assay
gener
increas
detect
rate
qpcr
assay
pronounc
h
influenza
aureu
pneumonia
rsv
tabl
supplement
tabl
uniqu
observ
qpcr
assay
versu
standard
test
vice
versa
highlight
tabl
notabl
two
five
specimen
posit
rsv
two
four
specimen
posit
pneumonia
qpcr
assay
analysi
mean
cq
valu
posit
identif
qpcr
assay
found
specimen
cultureposit
h
influenza
aureu
significantli
lower
valu
cultureneg
specimen
p
z
p
z
respect
suggest
high
cq
valu
repres
number
bacteria
detect
limit
cultur
data
shown
two
five
cultureposit
sputum
specimen
fals
neg
qpcr
assay
pneumonia
one
also
fals
neg
h
influenza
posit
inhibit
control
assay
indic
presenc
potent
inhibit
substanc
addit
two
npa
specimen
fals
neg
influenza
qpcr
assay
cq
valu
cycl
standard
qpcr
test
indic
low
viral
rna
abund
aim
develop
qpcr
assay
provid
clinic
use
inform
physician
evalu
cap
patient
develop
panel
target
eight
bacteria
six
virus
perform
assay
evalu
spike
sampl
clinic
respiratori
specimen
result
qpcr
assay
show
high
technic
perform
addit
show
superior
overal
perform
compar
standard
diagnost
method
use
laboratori
microorgan
commonli
regard
clinic
relev
identifi
new
assay
standard
test
importantli
main
differ
higher
sensit
new
qpcr
assay
compar
standard
test
improv
perform
result
larg
chang
diagnost
approach
standard
diagnost
test
involv
clinic
decis
includ
exclud
specif
test
wherea
new
assay
approach
reli
analysi
panel
caus
relev
evalu
patient
suspect
cap
distinct
advantag
new
assay
common
caus
cap
disregard
nontyp
clinic
present
challeng
design
diagnost
pcr
assay
find
appropri
balanc
technic
perform
one
hand
usabl
cost
hand
design
assay
high
demand
diagnost
perform
could
combin
eas
use
accept
cost
clinic
specimen
analyz
duplic
protocol
mean
provid
technic
control
pipet
potenti
handl
error
prepcr
process
downscal
one
reaction
per
sampl
would
simpl
task
prefer
laboratori
strongli
endors
howev
compromis
inclus
extern
posit
control
neg
notempl
control
ensur
proper
qualiti
control
qpcr
assay
uniformli
detect
gene
target
copi
per
reaction
importantli
true
agent
target
pcr
reaction
even
differ
target
dna
copi
number
well
known
potenti
limit
diagnost
pcr
assay
poor
amplif
effici
may
result
inhibitori
substanc
biolog
materi
analyz
interf
dna
prepar
step
pcr
amplif
step
expect
welldesign
assay
note
stabl
uniform
amplif
effici
microbi
dna
target
dilut
experi
perform
linear
plasmid
importantli
inhibit
rate
low
evalu
clinic
specimen
extens
inhibit
identifi
sputum
specimen
minor
inhibit
observ
increas
cq
valu
one
duplic
reaction
sputum
specimen
npa
specimen
support
reason
found
even
two
sputum
specimen
substanti
inhibit
amplif
target
target
still
amplifi
current
knowledg
gap
role
coinfect
patient
symptom
cap
hope
avail
assay
like
one
develop
help
fill
gap
report
indic
clinic
implic
coinfect
children
adult
wherea
other
suggest
littl
effect
coinfect
diseas
sever
outcom
studi
clearli
need
topic
ensur
futur
patient
suspicion
cap
respiratori
infect
receiv
best
possibl
treatment
evalu
qpcr
assay
consecut
collect
sputum
npa
specimen
found
ad
valu
combin
detect
bacteria
virus
assay
compar
tradit
strategi
analyz
respiratori
specimen
either
bacteri
viral
caus
combin
approach
show
superior
detect
agent
regard
clinic
relev
thu
ad
valu
combin
high
sensit
qpcr
assay
gener
particular
fact
infecti
agent
detect
initi
suspect
evid
bacteria
detect
often
qpcr
assay
standard
test
exemplifi
detect
pneumonia
specimen
former
assay
five
specimen
standard
cultur
method
superior
perform
qpcr
assay
detect
pneumonia
appli
nasopharyng
sputum
specimen
especi
sputum
notabl
cq
mean
valu
latter
often
low
indic
sever
cultureneg
specimen
contain
abund
pneumoniaespecif
nucleic
acid
find
indic
pcrbase
method
may
prefer
culturebas
method
detect
pneumonia
sputum
noteworthi
import
cap
pathogen
likewis
qpcr
assay
superior
detect
rsv
pneumonia
case
obviou
chang
diagnost
approach
provid
advantag
addit
detect
rsv
pneumonia
npa
sputum
specimen
respect
occur
low
cq
valu
indic
abund
nucleic
acid
two
agent
target
standard
test
perform
although
retrospect
like
clinic
relev
select
eight
bacteria
six
viral
agent
includ
new
assay
basi
judgment
would
import
agent
test
patient
cap
admit
hospit
select
may
question
acknowledg
sever
target
could
includ
panel
relev
evalu
cap
patient
believ
howev
agent
select
repres
reason
compromis
agent
interest
inclus
exclus
purpos
evalu
suspect
cap
natur
addit
microbi
agent
target
exampl
situat
sever
diseas
intens
care
unit
epidemiolog
suggest
spread
highli
pathogen
corona
virus
patient
popul
chronic
lung
diseas
longterm
hospit
patient
suspect
respiratori
infect
strength
studi
includ
high
technic
perform
assay
evalu
comparison
new
assay
standard
diagnost
approach
gener
found
good
agreement
enhanc
capabl
new
assay
detect
microbi
agent
commonli
regard
clinic
relev
exampl
pneumonia
pneumonia
rsv
limit
studi
includ
fact
studi
design
preclud
effect
evalu
clinic
relev
microbi
find
relev
exampl
increas
detect
aureu
h
influenza
qpcr
assay
uncertain
find
aureu
standard
cultur
method
respiratori
specimen
clinic
tradit
experi
regard
import
scenario
exampl
chronic
lung
diseas
concomit
sever
influenza
pneumon
consequ
increas
detect
new
assay
may
may
relev
likewis
clinician
may
argu
clinic
valu
increas
detect
h
influenza
uncertain
result
studi
suggest
applic
qpcr
assay
parallel
detect
bacteri
viral
agent
respiratori
specimen
cap
patient
feasibl
qpcr
approach
confer
obviou
advantag
much
rapid
standard
microbiolog
method
found
technic
robust
good
sensit
clinic
specimen
addit
obviou
import
clinic
advantag
panelbas
strategi
minim
risk
caus
search
bias
overlap
clinic
present
distinct
caus
importantli
assay
easili
modifi
addit
jmdamjpatholorg
journal
molecular
diagnost
target
panel
includ
detect
caus
exampl
relev
hospitalacquir
pneumonia
